Rewards
All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Politics
Business
Trending on Bing
Senate passes foreign aid
Victims get $139M settlement
Baldwin clash goes viral
Joins ‘Wednesday' S2 cast
Honors late husband on stage
Sued for harassment
'McCloud' actor dies at 95
Yale student killer sentenced
Biden boosts overtime pay
66-yr-old charged w/ murder
Past audition experiences
Tenn. armed teachers bill
Clark's Nike 8-year contract
Ends bid for Congress
Accident on 'The Pickup' set
Jones' Dover absence
‘Blink Twice’ trailer
$1B weapon aid for Ukraine
Abortion stance in Florida
Cash's unreleased tracks
Judge drops border charges
Bid against detention rejected
To unveil plan for new stadium
Stars charity challenge
'Party After Dark' tour
Fort Wayne mayor sworn in
Webby Awards winners
Next product event: May 7
X to launch TV app
Announces more layoffs
New US home sales rebound
Felon voting law struck down
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
precisionmedicineonline
4d
FDA Approves Genentech's Alecensa as Adjuvant Treatment for ALK-Positive Lung Cancer
With the FDA nod, Alecensa becomes the second molecularly targeted therapy to move into the adjuvant setting for non-small cell lung cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results